Thalidomide-associated gynecomasty in a patient with multiple myeloma [3]

American Journal of Hematology

Volumn 70, Issue 3, 2002, Pages 265-

  Pulik, Marc ^a   Genet, Philippe ^a   Lionnet, François ^a   Touahri, Tahar ^a  

^a CENTRE HOSPITALIER VICTOR DUPOUY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; ESTRADIOL; PROLACTIN; TESTOSTERONE; THALIDOMIDE; VINCRISTINE;

ADULT; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; CONSTIPATION; DIARRHEA; EMBRYOPATHY; FATIGUE; GYNECOMASTIA; HORMONE BLOOD LEVEL; HUMAN; HYPOTHYROIDISM; LETTER; MALE; MAMMOGRAPHY; MULTIPLE MYELOMA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RASH; VEIN THROMBOSIS; VERTIGO;

EID: 0036089171     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10128     Document Type: Letter

References (3)

1. Antitumor activity of thalidomide in refractory multiple myeloma
2. Increased risk of deep vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy
3. Clinical studies on teenage Brazilian victims of thalidomide